May 30, 2026 Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
May 30, 2026 Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026
May 30, 2026 True Health Brings Advanced Shockwave Therapy to Lombard as a Non-Surgical Solution for Chronic Pain
